Armistice Capital, LLC Merck & Co., Inc. Transaction History

Armistice Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $37.6 Million - $41.7 Million	-524,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $12 Million - $13.6 Million	164,000 Added 45.56%	524,000 $43.5 Million
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $4.23 Million - $4.81 Million	60,000 Added 20.0%	360,000 $27.8 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $13.9 Million - $19.3 Million	220,000 Added 275.0%	300,000 $23.1 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $4.34 Million - $4.9 Million	-56,000 Reduced 41.18%	80,000 $7.28 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $10.3 Million - $11.3 Million	136,000 New	136,000 $11.4 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $6.29 Million - $7.34 Million	-90,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $6.26 Million - $7.14 Million	90,000 New	90,000 $7.59 Million

3,830

1.91B

13.4M

10.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.